Biocides (Amendment) Regulations, 2009
Statutory Text (4 Articles)
L.N. 16 of 2009
PESTICIDES CONTROL ACT
(CAP. 430)
Biocides (Amendment) Regulations, 2009
IN exercise of the powers conferred by articles 4 and 5 of the
Pesticides Control Act, the Minister for Resources and Rural Affairs,
in consultation with the Prime Minister and with the Minister for
Social Policy, has made the following regulations:-
(1) The title of these regulations is the Biocides
(Amendment) Regulations, 2009 and they shall be read and construed
as one with Biocides Regulations, 2004, hereinafter referred to as
“the principal regulations”.
(2) The scope of these regulations is to transpose
Commission Directive 2007/47/EC of the European Parliament and of
the Council of 5 September 2007 amending Council Directive 90/385/
EEC on the approximation of the laws of the Member States relating
to active implantable medical devices, Council Directive 93/42/EEC
concerning medical devices and Directive 98/8/EC concerning the
placing of biocidal products on the market, Commission Directive
2008/15/EC of 15 February 2008 amending Directive 98/8/EC of
the European Parliament and of the Council to include clothianidin
as an active substance in Annex IA thereto, Commission Directive
2008/16/EC of 15 February 2008 amending Directive 98/8/EC of
the European Parliament and of the Council to include etofenprox
as an active substance in Annex I thereto, Commission Directive
2008/75/EC of 24 July 2008 amending Directive 98/8/EC of the
European Parliament and of the Council to include carbon dioxide
as an active substance in Annex I thereto, Commission Directive
2008/77/EC of 25 July 2008 amending Directive 98/8/EC of the
European Parliament and of the Council to include thiamethoxam
as an active substance in Annex I thereto, Commission Directive
2008/78/EC of 25 July 2008 amending Directive 98/8/EC of the
European Parliament and of the Council to include propiconazole
as an active substance in Annex I thereto, Commission Directive
2008/79/EC of 28 July 2008 amending Directive 98/8/EC of the
European Parliament and of the Council to include IPBC as an
active substance in Annex I thereto, Commission Directive 2008/80/
EC of 28 July 2008 amending Directive 98/8/EC of the European
Parliament and of the Council to include cyclohexylhydroxydiazene
1-oxide, potassium salt (K-HDO), Commission Directive 2008/81/
EC of 29 July 2008 amending Directive 98/8/EC of the European
Parliament and of the Council to include difenacoum as an active
substance in Annex I thereto, Commission Directive 2008/85/EC
of 5 September 2008 amending Directive 98/8/EC of the European
Parliament and of the Council to include thiabendazole as an active
substance in Annex I thereto, and Commission Directive 2008/86/EC
of 5 September 2008 amending Directive 98/8/EC of the European
Parliament and of the Council to include tebuconazole as an active
substance in Annex I thereto.
(1) In regulation 2(2) of the principal regulations,
immediately after item (r) thereof, there shall be added the
following:-
“(s) provisions concerning in vitro diagnostic medical
devices.”
In Schedule III to the principal regulations, immediately
after item 3 thereof, there shall be added the following new items:-
€0.28